Izvoz končan — 

Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab

BACKGROUND: Anti-angiogenic therapy with bevacizumab is the most widely used treatment option for recurrent glioblastoma, but therapeutic response varies substantially and effective biomarkers for patient selection are not available. To this end, we determine whether novel quantitative radiomic stra...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Grossmann, Patrick, Narayan, Vivek, Chang, Ken, Rahman, Rifaquat, Abrey, Lauren, Reardon, David A, Schwartz, Lawrence H, Wen, Patrick Y, Alexander, Brian M, Huang, Raymond, Aerts, Hugo J W L
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Neuroimaging
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716072/
https://ncbi.nlm.nih.gov/pubmed/28499022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox092
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki